松元 文孝 (マツモト フミタカ)

MATSUMOTO Fumitaka

写真a

所属

医学部 附属病院 脳神経外科

職名

助教

外部リンク

関連SDGs


学位 【 表示 / 非表示

  • 医学獣医学 ( 2021年11月   宮崎大学 )

  • 医学 ( 2006年3月   宮崎医科大学 )

 

論文 【 表示 / 非表示

  • A Rare Case of a Solid Variant Aneurysmal Bone Cyst of the Medial Sphenoid Bone: Clinical Features, Diagnostic Points, and Treatment.

    Yamashita S, Matsumoto F, Okuyama H, Ogasawara N, Tamura M, Kawano T, Yokogami K, Kiwaki T, Fukushima T, Sato Y, Tomonaga T, Okita Y

    NMC case report journal   12 ( 0 )   369 - 375   2025年

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:一般社団法人 日本脳神経外科学会  

    A 5-year-old boy presented to our hospital with ptosis and an abnormal ocular position. Magnetic resonance imaging showed a well-defined mass measuring 20 mm in diameter in the medial sphenoid bone extending to the orbit and compressing the external ocular muscle. The patient underwent total surgical excision and was subsequently diagnosed with a solid variant of aneurysmal bone cyst via molecular integrated diagnosis. Solid variant of aneurysmal bone cyst is an extremely rare subtype of aneurysmal bone cyst, accounting for 0.2% of all primary bone tumors. It is characterized by the absence of a solid cystic component, which is difficult to diagnose via conventional hematoxylin and eosin staining. Molecular analyses revealed that this subtype is also characterized by the rearrangement of <i>USP6</i> and the absence of the H3F3A mutation. This report discusses the clinical features of this extremely rare neoplastic lesion, the importance of an integrated diagnosis, and treatment options.

    DOI: 10.2176/jns-nmc.2025-0055

    PubMed

    CiNii Research

  • Primary Intracranial Ewing Sarcoma Arising from the Cavernous Sinus in an Older Woman with a History of Intensive Breast Cancer Treatment: A Case Report.

    Kawano T, Matsumoto F, Yamashita S, Oguri N, Akizuki K, Tomonaga T, Akiyama Y, Kadota Y, Oda Y, Azuma M, Yamashita A, Okita Y

    NMC case report journal   12 ( 0 )   525 - 530   2025年

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:一般社団法人 日本脳神経外科学会  

    A 72-year-old woman with a history of breast cancer presented with left oculomotor nerve palsy. Magnetic resonance imaging revealed a progressive mass lesion in the cavernous sinus. Initially, Tolosa-Hunt syndrome and metastatic brain tumor from breast cancer were suspected; however, radiological differentiation proved challenging. Pathological examination confirmed the diagnosis of primary intracranial Ewing sarcoma. The tumor exhibited progressive growth, and Gamma Knife radiosurgery was performed. After treatment, tumor shrinkage and symptomatic improvement were observed. Ewing sarcoma typically occurs in children and young adults; however, the safety and efficacy of chemotherapy in older populations remain largely unstudied. In this older patient, the rare location of the tumor within the cavernous sinus posed challenges to surgical resection. Chemotherapy was administered at a reduced dose of 50%, with limited side effects. After 7 cycles of chemotherapy, tumor showed further shrinkage, and no recurrence was observed. This case demonstrates that, even in rare tumors with unestablished chemotherapy protocols for older patients, satisfactory outcomes can be achieved with accurate pathological diagnosis and a multidisciplinary treatment approach.

    DOI: 10.2176/jns-nmc.2025-0138

    PubMed

    CiNii Research

  • Targeting cholesterol biosynthesis for AT/RT: comprehensive expression analysis and validation in newly established AT/RT cell line 査読あり

    Matsumoto F., Yokogami K., Yamada A., Moritake H., Watanabe T., Yamashita S., Sato Y., Takeshima H.

    Human Cell   37 ( 2 )   523 - 530   2024年3月

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Human Cell  

    Atypical teratoid/rhabdoid (AT/RT) is a rare and highly malignant tumor of the central nervous system (CNS). It is most commonly found in children less than 5 years of age and is associated with inactivation of loss of function of SMARCB1/INI1. An experimental model for AT/RT is necessary to develop new and effective therapies. We established a patient-derived new cell line (MZ611ATRT), which showed loss of BAF-47. MZ611ATRT genetically features somatic heterozygous deletion of SMARCB1 and single nucleotide deletion of the residual allele, exon 5 ([c.541delC]), resulting in a stop codon at codon 954 by frameshift. We assessed the RNA-sequencing data of the other two AT/RT cell lines with forced expression of SMARCB1 available from public databases. We found SMARCB1 overexpression significantly down-regulates the expression of a group of enzymes related to cholesterol biosynthesis. Simvastatin was highly sensitive against MZ611ATRT cells and induced apoptosis (IC50 was 3.098 µM for MZ611ATRT, 41.88uM for U-87 MG, 23.34uM for IOMM-Lee, and 18.12uM for U-251 MG.). Pathways involved in cholesterol biosynthesis may be new targets for adjuvant therapy of AT/RT.

    DOI: 10.1007/s13577-023-01022-1

    Scopus

    PubMed

  • Spontaneous malignant transformation of trigeminal schwannoma: consideration of responsible gene alterations for tumorigenesis—a case report 査読あり

    Ogasawara N., Yamashita S., Yamasaki K., Kawano T., Kawano T., Muta J., Matsumoto F., Watanabe T., Ohta H., Yokogami K., Fukushima T., Sato Y., Takeshima H.

    Brain Tumor Pathology   40 ( 4 )   222 - 229   2023年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Brain Tumor Pathology  

    Malignant peripheral nerve sheath tumors (MPNSTs) arising from the trigeminal nerves are extremely rare (only 45 cases, including the present case, have been published) and have been reported to develop de novo from the peripheral nerve sheath and are not transformed from a schwannoma or neurofibroma. Here, we report a case of MPNSTs of the trigeminal nerve caused by the malignant transformation of a trigeminal schwannoma, with a particular focus on genetic considerations. After undergoing a near-total resection of a histologically typical benign schwannoma, the patient presented with regrowth of the tumor 10 years after the primary excision. Histopathologic and immunochemical examinations confirmed the recurrent tumor to be an MPNST. Comprehensive genomic analyses (FoundationOne panel-based gene assay) showed that only the recurrent MPNST sample, not the initial diagnosis of schwannoma, harbored genetic mutations, including NF1-p.R2637* and TP53-p.Y234H, candidate gene mutations associated with malignant transformation. Moreover, the results of reverse transcription polymerase chain reaction showed that the fusion of SH3PXD2A and HTRA1, which has been reported as one of the responsible genetic aberrations of schwannoma, was detected in the recurrent tumor. Taken together, we could illustrate the accumulation process of gene abnormalities for developing MPNSTs from normal cells via schwannomas.

    DOI: 10.1007/s10014-023-00466-5

    Scopus

    PubMed

  • Rare solitary pituitary metastasis of maxillary ameloblastic carcinoma: illustrative case 査読あり

    Arikawa S., Watanabe T., Yamaguchi H., Sato Y., Matsumoto F., Yokogami K., Takeshima H.

    Journal of Neurosurgery: Case Lessons   6 ( 10 )   2023年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Journal of Neurosurgery: Case Lessons  

    BACKGROUND Ameloblastic carcinoma (AC) is a rare odontogenic carcinoma with histological features resembling ameloblastoma. Metastasis to distant organs and direct expansion into the skull base structures are associated with a poor clinical outcome. This rare case of AC metastasis to the pituitary gland presented without local recurrence at the primary focus of the maxilla. OBSERVATIONS A 47-year-old man had a 2-year history of AC in the right maxilla. Computed tomography for his regular checkup incidentally demonstrated pituitary tumor, rapidly growing over 2 months. He presented with the recent onset of panhypopituitarism and visual field defect. Magnetic resonance imaging showed a large, irregularly shaped intrasellar and suprasellar lesion with chiasmal compression. Endoscopic endonasal transsphenoidal surgery was performed for decompression of the optic apparatus to avoid intracranial spread. Histopathology confirmed metastatic AC, and a genetic panel test confirmed BRAF V600E mutation. Stereotactic radiotherapy (SRT) with the CyberKnife system was administered to the residual tumor. Remarkable tumor shrinkage was obtained, and panhypopituitarism was resolved 12 months later. LESSONS A multidisciplinary treatment strategy including maximal safe resection to avoid dissemination in combination with SRT may be crucial for local control with the preservation of pituitary and visual functions in patients with solitary pituitary metastatic AC.

    DOI: 10.3171/CASE23264

    Scopus

    PubMed

全件表示 >>

講演・口頭発表等 【 表示 / 非表示

  • 悪性神経膠腫の増殖血管における上皮間転換の検出.

    松元文孝

    第36回日本脳腫瘍学会学術集会 

     詳細を見る

    開催年月日: 2018年12月2日 - 2018年12月4日

    記述言語:日本語   会議種別:口頭発表(一般)  

  • Detection of TERT promoter mutation in proliferated Vascular cells of malignant glioma.

    Matsumoto F

    The 15th Kyushyu and Yong-Honam Neurosurgical Joint Meeting 

     詳細を見る

    開催年月日: 2018年11月

    記述言語:英語   会議種別:口頭発表(一般)  

  • 内視鏡手術前のMRI, CT合成3Dイメージ作成の有効性について.

    松元文孝、田村充、武石剛、竹島秀雄

    第25回日本神経内視鏡学会 

     詳細を見る

    開催年月日: 2018年10月26日 - 2018年10月27日

    記述言語:日本語   会議種別:口頭発表(一般)  

  • 宮崎県における10年間の原発性脳腫瘍の疫学調査.

    松元文孝

    日本脳神経外科学会第77回学術総会 

     詳細を見る

    開催年月日: 2018年10月10日 - 2018年10月12日

    記述言語:日本語   会議種別:口頭発表(一般)  

  • DIPGの憎悪に放射線再照射を併用した一例

    松元文孝

    第46回日本小児脳神経外科学会 

     詳細を見る

    開催年月日: 2018年6月8日 - 2018年6月9日

    記述言語:英語   会議種別:口頭発表(一般)  

全件表示 >>

科研費(文科省・学振・厚労省)獲得実績 【 表示 / 非表示

  • 退形成乏突起神経膠腫(grade3)を乏突起神経膠腫(grade2) に逆行させる治療薬の開発

    研究課題/領域番号:25K19939  2025年04月 - 2027年03月

    独立行政法人日本学術振興会  科学研究費基金  若手研究

     詳細を見る

    担当区分:研究代表者